Scientific Sessions 2024  /  Practicing what we preach – solutions for better implementation of secondary CVD prevention. (AHA Joint Session with World Heart Federation)  /  Fixed-dose combination therapy: Opportunities and challenges for improved CVD prevention
Logo

American Heart Association

  172
  0

Final ID:

Fixed-dose combination therapy: Opportunities and challenges for improved CVD prevention

  • Prabhakaran, Dorairaj  ( Centre for Chronic Disease Control , Delhi , India )
  • Murphy, Adrianna  ( London School of Hygiene and Tropical Medicine , London , United Kingdom )
  • Irazola, Vilma  ( IECS , Buenos Aires , Argentina )
    • Author Disclosures:
    Dorairaj Prabhakaran: DO have relevant financial relationships ; Research Funding (PI or named investigator):SERDIA PHARMACEUTICALS (INDIA) PRIVATE LIMITED:Past (completed) ; Research Funding (PI or named investigator):Servier Affaires Médicales:Active (exists now) ; Research Funding (PI or named investigator):Imperial College London:Active (exists now) | Adrianna Murphy: No Answer | Vilma Irazola: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Practicing what we preach – solutions for better implementation of secondary CVD prevention. (AHA Joint Session with World Heart Federation)

Monday, 11/18/2024 , 09:45AM - 11:00AM

Joint Session

More abstracts on this topic:
Translating knowledge into action for those at highest CVD risk: The WHF Secondary Prevention Roadmap

Pineiro Daniel, Narula Jagat, Gaziano Thomas

Harnessing Mobile Health Technology for Enhancing Secondary CVD Prevention

Schorr Erica, Wang Tracy

More abstracts from these authors:
Discussant: BPROAD

Prabhakaran Dorairaj

AI for Global Cardiovascular Health: Advancing Ethical, Equitable, and Scalable Solutions

Ribeiro Antonio Luiz, Prabhakaran Dorairaj

You have to be authorized to contact abstract author. Please, Login
Not Available